Circulating TP53 mutations are predictive and prognostic biomarkers in pancreatic cancer patients treated with FOLFIRINOX chemotherapy
Titel:
Circulating TP53 mutations are predictive and prognostic biomarkers in pancreatic cancer patients treated with FOLFIRINOX chemotherapy
Auteur:
Van Der Sijde, F. Azmani, Z. Besselink, M. Bonsing, B. de Groot, J.W. Koerkamp, B. Groot Haberkorn, B. Homs, M. van Ijcken, W. Janssen, Q. Lolkema, M. Luelmo, S. Mekenkamp, L. Mustafa, D. van Schaik, R. Wilmink, J. van Eijck, C. Vietsch, E.